SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-200606
Filing Date
2024-08-14
Accepted
2024-08-14 16:01:53
Documents
14
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d857974d8k.htm   iXBRL 8-K 26155
2 EX-99.1 d857974dex991.htm EX-99.1 53565
  Complete submission text file 0001193125-24-200606.txt   212289

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA scph-20240814.xsd EX-101.SCH 2881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20240814_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20240814_pre.xml EX-101.PRE 11282
16 EXTRACTED XBRL INSTANCE DOCUMENT d857974d8k_htm.xml XML 3633
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 241207314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)